Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes

Change (%-Points) From Baseline in HbA1c (Glycosylated Haemoglobin A1c)

Change in HbA1c (%-points) was calculated as the difference between the HbA1c (%) at Week 0 and Week 56.

Time frame: Week 0, week 56

Proportion of Subjects Reaching Target HbA1c Below 7%

Time frame: at 56 weeks

Proportion of Subjects Reaching Target HbA1c Below or Equal to 6.5%

Time frame: at 56 weeks

Change From Baseline in Waist Circumference

Time frame: Week 0, week 56

Change (%) From Baseline in Body Weight (Fasting)

Weight was recorded to the nearest 0.1 kg for a subject in the fasting state with an empty bladder, without shoes and only wearing light clothing. The same calibrated scale was used throughout the trial.

Time frame: Week 0, week 68

Change (%) From Week 56 to 68 in Body Weight (Fasting)

Weight was recorded to the nearest 0.1 kg for a subject in the fasting state with an empty bladder, without shoes and only wearing light clothing. The same calibrated scale was used throughout the trial.

Time frame: Week 56, week 68

Change From Baseline in Waist Circumference

Time frame: Week 0, week 68

Change From Week 56 to 68 in Waist Circumference

Time frame: Week 56, week 68

Incidence of Hypoglycaemic Episodes

Hypoglycaemic episodes were classified according to American Diabetes Association (ADA) definitions as well as to the Novo Nordisk definition of a minor hypoglycaemic event (blood glucose level below approximately 2.8 mmol/L \[50 mg/dL\] or plasma glucose level below 3.1 mmol/L \[56 mg/dL\]).

Time frame: Weeks 0-56